Narrow Your Results

Strategy

Sections

Showing 1 - 4 of 4 Results for "co-infection"

Results

Gap
Increased efforts are needed to actively plan for screening and treating HIV-TB co-infection, particularly in antenatal clinics. A study found no planning for HIV-TB co-infection across all levels of the health care system. Other studies found separate services and no information for co-infected patients on the risks of co-infection, plus no screening and treatment of co-infection. [See also %{c:17}]
Tuberculosis
1 study
Further research is needed on infant transmission risks of malaria and/or HIV in pregnant women who have malaria-HIV co-infection.
Malaria
1 study
Further research is needed to determine the appropriate timing of initiating ART for TB/HIV co-infected patients. Studies conflict with regard to timing of TB therapy and ART for those patients with CD4 counts below 200. Studies also conflict with regard to timing for ART for patients with extra-pulmonary TB.
Tuberculosis
1 study
Further studies are needed to determine whether standard intermittent preventive treatment and antiretroviral therapy regimens are medically and operationally compatible in pregnancy and to determine safe and effective protocols for management of concurrent HIV and malarial infections in pregnant and non-pregnant women living with HIV. A study found that alternative malarial drug regimens should be considered for HIV/malaria co-infected patients receiving nevirapine.
Malaria
1 study